Table 2 summarizes the hazard ratio (HR) and associated 95% confidence intervals (CI) of breast cancer associated with plasma OPG levels among BRCA1 and BRCA2 mutation carriers. This evidence concerns the gene TNFRSF11B and breast cancer.